Abbreviations: bid, "bis in die" = twice daily; BMI, body mass index; SAD/MAD, single/multiple ascending dose. 
Figure 1.
Gastrointestinal adverse events after first intake with probable or possible connection to cellobiose intake. This figure shows the number of the adverse events with probable or possible connection to cellobiose intake (diarrhoea, borborygmus, flatulence) by cohorts. Shading stands for light (white), moderate (grey) or severe (black) adverse events. The dosage of cellobiose is indicated. Dosage groups without AEs are not shown. Small letters indicate identical subjects with multiple adverse events. The subject marked by an asterisk also suffered from "light discomfort". Abbreviations: bid, "bis in die" = twice daily.
